Literature DB >> 3145770

CSF soluble proteins and vigabatrin.

L Persson.   

Abstract

Mesh：

Substances：

Year:  1988        PMID： 3145770

Source DB:  PubMed          Journal:  Br J Clin Pract Suppl        ISSN： 0262-8767


× No keyword cloud information.
  3 in total

Review 1.  Vigabatrin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in epilepsy and disorders of motor control.

Authors:  S M Grant; R C Heel
Journal:  Drugs       Date:  1991-06       Impact factor: 9.546

2.  Changes in CSF and brain soluble proteins following vigabatrin treatment in rats.

Authors:  L I Persson; L Rönnbäck; E Ben-Menachem; P Eriksson; M Nilsson
Journal:  Br J Clin Pharmacol       Date:  1989       Impact factor: 4.335

3.  Effects of vigabatrin on evoked potentials in epileptic patients.

Authors:  V Cosi; R Callieco; C A Galimberti; R Manni; A Tartara; J Mumford; E Perucca
Journal:  Br J Clin Pharmacol       Date:  1989       Impact factor: 4.335
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.